Acetaminophen / phenyltoloxamine / salicylamide Pregnancy and Breastfeeding Warnings

Acetaminophen / phenyltoloxamine / salicylamide is also known as: Anabar, Be-Flex Plus, By-Ache, Dolorex, Duraxin, Ed-Flex, Lobac

Acetaminophen / phenyltoloxamine / salicylamide Pregnancy Warnings

It is not known whether acetaminophen/phenyltoloxamine/salicylamide can cause fetal harm when administered to a pregnant women or can affect reproduction capability. Two cases of acetaminophen overdose in late pregnancy have been reported. In both cases neither the neonate nor the mother suffered hepatic toxicity. Investigations have revealed conflicting results with regards to the pharmacokinetic disposition of acetaminophen in pregnant women. One study has suggested that the oral clearance of acetaminophen is 58% higher and the elimination half-life is 28% longer in pregnant women compared to nonpregnant women. Another study has suggested that the elimination half-life is not different in patients who are pregnant. That study also suggested that the volume of distribution of acetaminophen may be higher in pregnant women. One study has suggested that acetaminophen in typical oral doses may result in a reduced production of prostacyclin in pregnant women. That study also suggested that acetaminophen does not affect thromboxane production.

The combination drug acetaminophen, phenyltoloxamine, and salicylamide has been assigned to pregnancy category C by the FDA. Animal studies have not been conducted on this combination product. There are no controlled data in human pregnancy. The combination drug acetaminophen, phenyltoloxamine, and salicylamide should only be given during pregnancy when benefits outweigh risks.

Acetaminophen / phenyltoloxamine / salicylamide Breastfeeding Warnings

There are no data on the excretion of the combination drug acetaminophen, phenyltoloxamine, and salicylamide into human milk. Acetaminophen is excreted into human milk in small concentrations. One case of a rash has been reported in a nursing infant. Acetaminophen is considered compatible with breast-feeding by the American Academy of Pediatrics. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions due to the combination drug acetaminophen, phenyltoloxamine, and salicylamide in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

One small study has reported that following a 1000 mg dose of acetaminophen to nursing mothers, nursing infants receive less than 1.85% of the weight-adjusted maternal oral dose.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web2)